![Sativex oromucosal cannabis based medicine (photo: Ethan Russo , 2003) | Download Scientific Diagram Sativex oromucosal cannabis based medicine (photo: Ethan Russo , 2003) | Download Scientific Diagram](https://www.researchgate.net/profile/Ethan-Russo/publication/6126756/figure/fig1/AS:277764411281430@1443235604530/Sativex-oromucosal-cannabis-based-medicine-photo-Ethan-Russo-2003_Q320.jpg)
Sativex oromucosal cannabis based medicine (photo: Ethan Russo , 2003) | Download Scientific Diagram
![Biomolecules | Free Full-Text | Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders Biomolecules | Free Full-Text | Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders](https://pub.mdpi-res.com/biomolecules/biomolecules-10-00279/article_deploy/html/images/biomolecules-10-00279-g002.png?1583561790)
Biomolecules | Free Full-Text | Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
Canna Product 420 - canna_product_420 What is Sativex? Sativex® is a cannabis-based product classified as a Schedule 2, Part 1 (Class B1) controlled drug product under the Misuse of Drugs Act 1975.
![Thin-layer chromatography (TLC) of a sample of hashish (cannabis resin,... | Download Scientific Diagram Thin-layer chromatography (TLC) of a sample of hashish (cannabis resin,... | Download Scientific Diagram](https://www.researchgate.net/publication/327530480/figure/fig1/AS:679057888923648@1538911425032/Thin-layer-chromatography-TLC-of-a-sample-of-hashish-cannabis-resin-or-soapbar.png)
Thin-layer chromatography (TLC) of a sample of hashish (cannabis resin,... | Download Scientific Diagram
![Brasilien: Anvisa setzt Charge von Sativex wegen unzureichendem Gehalt an CBD und THC aus - CannaReporter Brasilien: Anvisa setzt Charge von Sativex wegen unzureichendem Gehalt an CBD und THC aus - CannaReporter](https://cannareporter.eu/wp-content/uploads/2021/08/mevatyl-ovgyxn1qicf78nw25p0lecj4rb0y7ba558js9k56le.jpg)
Brasilien: Anvisa setzt Charge von Sativex wegen unzureichendem Gehalt an CBD und THC aus - CannaReporter
![PDF) A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex (R) (nabiximols) PDF) A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex (R) (nabiximols)](https://i1.rgstatic.net/publication/51606259_A_placebo-controlled_parallel-group_randomized_withdrawal_study_of_subjects_with_symptoms_of_spasticity_due_to_multiple_sclerosis_who_are_receiving_long-term_Sativex_R_nabiximols/links/5ad0f6f90f7e9b285932348c/largepreview.png)
PDF) A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex (R) (nabiximols)
![Frontiers | Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey Frontiers | Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey](https://www.frontiersin.org/files/MyHome%20Article%20Library/784748/784748_Thumb_400.jpg)